Browse every story filed under this topic, curated from trusted publishers around the world.
A new policy that recommends offering hepatitis B vaccine at birth only to babies perceived to be at risk will lead to increased numbers of infected infants and more cases…
Read full story →
How much you sleep matters, but research shows poor sleep regularity is linked to greater risk of Alzheimer’s.
While it’s no cure-all, researchers say eating it as little as once a week may help manage cholesterol, support blood …
New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major cardiovascular …
Recent studies have suggested that sugar substitutes might not be the free lunch they're advertised as. We asked experts what …
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression …
The FDA is issuing national priority vouchers to three companies studying psychedelic drugs to treat serious mental illness. The vouchers …
A pair of new studies suggest tirzepatide can keep heart disease at bay in high-risk groups.
Avalyn Pharma is hoping to rake in around $181.8 million from an IPO, which the biotech will use to take …
As the Penn Relays got underway Thursday, a renowned track athlete spoke to business students at Penn's Center for Africana …
In global nephrology studies, aligning biology, design, operations, and interpretation across regions is essential for avoiding small missteps that could …
Evolving studies suggest low‑dose aspirin may cut the risk of certain cancers and slow metastasis.
The U.S. military has used up nearly half of its stockpile of Patriot air defense interceptor missiles and heavily expended …
New York Jets general manager Darren Mougey says the team recently canceling its pre-draft visit with top pass rushing prospect …
Paradigm's SPIRE is designed to allow more routine care providers in community and rural settings to participate in post-marketing studies. …
Positive data from AstraZeneca's MIRANDA trial follows the OBERON and TITANIA studies of tozorakimab in COPD. The post AstraZeneca’s COPD …
You've seen all articles for #studies.
Check back
soon
for new stories.